ARCHIVES

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Panel Tells Carter Cancer Program Needs More Money

March 4, 1977

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

June 18, 1982

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

February 8, 1991